• LAST PRICE
    9.3700
  • TODAY'S CHANGE (%)
    Trending Up0.0400 (0.4287%)
  • Bid / Lots
    9.0300/ 1
  • Ask / Lots
    9.4900/ 28
  • Open / Previous Close
    9.3400 / 9.3300
  • Day Range
    Low 9.3300
    High 9.7600
  • 52 Week Range
    Low 8.1300
    High 11.7100
  • Volume
    1,093,731
    above average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Thursday's close: 9.33
TimeVolumeTBPH
09:32 ET37749.4
09:34 ET1009.41
09:36 ET6009.39
09:38 ET4009.41
09:39 ET12009.54
09:41 ET19889.55
09:43 ET17859.55
09:45 ET4009.525
09:48 ET15239.52
09:50 ET32089.5
09:52 ET3009.48
09:54 ET12439.46
09:56 ET6009.47
09:57 ET15649.5
09:59 ET20009.505
10:01 ET32009.515
10:03 ET27139.5
10:06 ET34609.525
10:08 ET11009.505
10:10 ET74439.62
10:12 ET6889.64
10:15 ET24169.7
10:17 ET13069.73
10:19 ET10439.76
10:21 ET16999.72
10:24 ET3009.73
10:26 ET67179.73
10:28 ET22959.64
10:30 ET8009.66
10:32 ET9009.62
10:35 ET9009.635
10:37 ET297809.72
10:39 ET379959.58
10:42 ET21009.58
10:44 ET2009.54
10:46 ET37799.56
10:48 ET7139.545
10:50 ET2009.54
10:53 ET2239.55
10:57 ET32149.54
11:00 ET13339.54
11:02 ET15519.53
11:04 ET2009.51
11:06 ET7009.49
11:08 ET1009.47
11:09 ET12229.47
11:11 ET3009.47
11:13 ET24209.5
11:15 ET8699.475
11:20 ET12769.47
11:22 ET1239.47
11:24 ET7009.43
11:26 ET1249.42
11:31 ET1009.4
11:33 ET4009.44
11:36 ET16449.48
11:38 ET1009.48
11:40 ET7139.47
11:42 ET5011179.46
11:45 ET16859.48
11:47 ET2009.48
11:49 ET2009.47
11:51 ET13699.43
11:54 ET1009.41
11:56 ET1009.415
11:58 ET10009.43
12:02 ET2009.46
12:03 ET188069.53
12:05 ET3009.52
12:07 ET15269.51
12:14 ET11009.45
12:16 ET1009.46
12:20 ET2009.46
12:21 ET2009.46
12:23 ET6009.45
12:27 ET1009.44
12:30 ET2009.42
12:32 ET5009.41
12:34 ET9929.39
12:36 ET1009.38
12:39 ET20199.455
12:41 ET1009.45
12:43 ET114009.45
12:45 ET19009.415
12:48 ET6009.4
12:52 ET16009.41
12:54 ET39209.4
12:56 ET7119.4
12:59 ET1009.4
01:01 ET6629.4
01:03 ET10539.3857
01:08 ET28859.4
01:14 ET2009.4
01:19 ET1009.385
01:21 ET13009.385
01:24 ET4009.4
01:26 ET6009.37
01:28 ET2009.39
01:30 ET2009.37
01:32 ET3009.37
01:33 ET2009.38
01:35 ET32329.4
01:37 ET5589.4
01:42 ET19279.385
01:44 ET70029.39
01:46 ET3009.375
01:48 ET57049.38
01:51 ET15839.37
01:55 ET28099.39
01:57 ET2009.39
02:00 ET32739.38
02:02 ET8009.37
02:04 ET17519.36
02:06 ET1329.36
02:08 ET4009.36
02:09 ET12009.36
02:11 ET4999.35
02:13 ET10199.35
02:15 ET11969.35
02:18 ET10809.35
02:20 ET9209.37
02:22 ET5009.38
02:24 ET5009.37
02:26 ET8559.375
02:27 ET10629.37
02:29 ET8009.36
02:31 ET28009.4
02:33 ET3009.39
02:36 ET4009.38
02:38 ET20009.37
02:40 ET7009.38
02:42 ET15009.38
02:44 ET8009.385
02:45 ET9999.38
02:47 ET24009.38
02:49 ET7009.37
02:51 ET16289.37
02:54 ET19009.36
02:56 ET38389.34
02:58 ET74609.38
03:00 ET7009.37
03:02 ET8009.37
03:03 ET8009.385
03:05 ET7009.37
03:07 ET17009.39
03:09 ET47489.38
03:12 ET8009.385
03:14 ET10009.385
03:16 ET17009.39
03:18 ET5009.39
03:20 ET49219.435
03:21 ET15959.44
03:23 ET18009.42
03:25 ET18009.4245
03:27 ET15009.43
03:30 ET29009.42
03:32 ET40209.415
03:34 ET34729.44
03:36 ET22269.44
03:38 ET34219.41
03:39 ET22009.42
03:41 ET36009.4
03:43 ET44959.4
03:45 ET10009.395
03:48 ET52979.39
03:50 ET40009.38
03:52 ET92269.38
03:54 ET72999.37
03:56 ET93069.355
03:57 ET133849.35
03:59 ET140129.37
Data delayed at least 15 minutes.
No documents available
0 New Today
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesTBPH
Theravance Biopharma Inc
455.7M
-10.9x
---
United StatesDSNKY
Daiichi Sankyo Co Ltd
73.4B
57.3x
---
United StatesEYPT
EyePoint Pharmaceuticals Inc
538.0M
-5.7x
---
United StatesSMTI
Sanara Medtech Inc
249.1M
-49.2x
---
United StatesAQST
Aquestive Therapeutics Inc
243.1M
-6.2x
---
United StatesOPTN
OptiNose Inc
183.9M
-4.6x
---
As of 2024-07-13

Company Information

Theravance Biopharma, Inc. is a biopharmaceutical company primarily focused on the development, and commercialization of medicines. Its product, YUPELRI (revefenacin) inhalation solution is indicated for the maintenance treatment of patients with chronic obstructive pulmonary disease (COPD). YUPELRI is a prescription medicine used to treat COPD, a long-term lung disease that includes chronic bronchitis, emphysema, or both. YUPELRI is an anticholinergic medicine, which helps the muscles around the airway in lungs stay relaxed to prevent symptoms, such as wheezing, shortness of breath and others. Its pipeline of internally discovered programs is targeted to address unmet patient needs. Ampreloxetine, its late-stage investigational norepinephrine reuptake inhibitor in development for symptomatic neurogenic orthostatic hypotension. Its Selective 5-HT4 Agonist (TD-8954) is a selective 5-HT4 receptor agonist, which is developed for the treatment of gastrointestinal motility disorders.

Contact Information

Headquarters
UGLAND HOUSE, SOUTH CHURCH STREETGEORGE TOWN, Cayman Islands KY1-1104
Phone
---
Fax
---

Executives

Chairman of the Board, Chief Executive Officer
Rick Winningham
Chief Financial Officer, Senior Vice President
Aziz Sawaf
Senior Vice President, General Counsel, Secretary
Brett Grimaud
Senior Vice President - Commercial and Medical Affairs, Chief Business Officer
Rhonda Farnum
Senior Vice President - Development and Head of Ireland Office
Aine Miller

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$455.7M
Revenue (TTM)
$61.5M
Shares Outstanding
48.6M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
0.25
EPS
$-0.86
Book Value
$4.43
P/E Ratio
-10.9x
Price/Sales (TTM)
7.4
Price/Cash Flow (TTM)
---
Operating Margin
-68.82%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.